BSE Live
Oct 03, 16:01Prev. Close
1394.55
Open Price
1380.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
Key Financial Ratios of 3B BlackBio Dx (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 55.51 | 39.86 | 2.88 | 10.69 | 2.29 | |
Diluted EPS (Rs.) | 55.51 | 39.86 | 2.88 | 10.69 | 2.29 | |
Cash EPS (Rs.) | 56.51 | 40.94 | 3.29 | 11.08 | 2.56 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 318.36 | 265.84 | 32.33 | 31.94 | 30.24 | |
Book Value [InclRevalReserve]/Share (Rs.) | 318.36 | 265.84 | 32.33 | 31.94 | 30.24 | |
Dividend / Share(Rs.) | 4.00 | 3.00 | 2.50 | 2.50 | 9.00 | |
Revenue from Operations/Share (Rs.) | 105.66 | 82.54 | 16.01 | 20.72 | 19.16 | |
PBDIT/Share (Rs.) | 75.72 | 55.35 | 4.21 | 11.83 | 3.35 | |
PBIT/Share (Rs.) | 74.72 | 54.34 | 3.80 | 11.44 | 3.09 | |
PBT/Share (Rs.) | 74.61 | 54.20 | 3.54 | 11.30 | 2.78 | |
Net Profit/Share (Rs.) | 55.51 | 39.93 | 2.88 | 10.69 | 2.29 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 71.66 | 67.05 | 26.28 | 57.07 | 17.50 | |
PBIT Margin (%) | 70.72 | 65.83 | 23.74 | 55.20 | 16.10 | |
PBT Margin (%) | 70.61 | 65.66 | 22.09 | 54.51 | 14.51 | |
Net Profit Margin (%) | 52.53 | 48.37 | 18.00 | 51.58 | 11.96 | |
Return on Networth / Equity (%) | 17.43 | 15.02 | 8.91 | 33.46 | 7.58 | |
Return on Capital Employed (%) | 22.95 | 19.99 | 10.94 | 33.37 | 9.52 | |
Return on Assets (%) | 16.00 | 13.69 | 7.23 | 25.33 | 5.94 | |
Total Debt/Equity (X) | 0.00 | 0.00 | 0.08 | 0.11 | 0.09 | |
Asset Turnover Ratio (%) | 0.33 | 0.51 | 0.39 | 0.51 | 0.50 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 6.81 | 6.79 | 5.97 | 4.12 | 4.98 | |
Quick Ratio (X) | 6.37 | 6.32 | 5.18 | 3.67 | 4.40 | |
Inventory Turnover Ratio (X) | 3.07 | 3.60 | 2.88 | 3.73 | 3.07 | |
Dividend Payout Ratio (NP) (%) | 0.00 | 6.40 | 86.55 | 84.03 | 0.00 | |
Dividend Payout Ratio (CP) (%) | 0.00 | 6.24 | 75.85 | 81.09 | 0.00 | |
Earnings Retention Ratio (%) | 0.00 | 93.60 | 13.45 | 15.97 | 0.00 | |
Cash Earnings Retention Ratio (%) | 0.00 | 93.76 | 24.15 | 18.91 | 0.00 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 1,322.97 | 605.26 | 312.56 | 256.34 | 213.58 | |
EV/Net Operating Revenue (X) | 14.61 | 8.56 | 26.05 | 16.51 | 14.88 | |
EV/EBITDA (X) | 20.39 | 12.76 | 99.11 | 28.93 | 84.98 | |
MarketCap/Net Operating Revenue (X) | 15.30 | 9.32 | 25.96 | 16.47 | 14.86 | |
Retention Ratios (%) | 0.00 | 93.59 | 13.44 | 15.96 | 0.00 | |
Price/BV (X) | 5.08 | 2.89 | 12.86 | 10.68 | 9.42 | |
Price/Net Operating Revenue | 15.30 | 9.32 | 25.96 | 16.47 | 14.86 | |
Earnings Yield | 0.03 | 0.05 | 0.01 | 0.03 | 0.01 |
05.06.2025
3B BlackBio Dx Standalone March 2025 Net Sales at Rs 23.02 crore, up 4.7% Y-o-Y
03.06.2025
3B BlackBio Dx Consolidated March 2025 Net Sales at Rs 22.50 crore, down 2.19% Y-o-Y
05.03.2025
3B BlackBio Dx Consolidated December 2024 Net Sales at Rs 25.39 crore, up 43.71% Y-o-Y
28.11.2024
3B BlackBio Dx Consolidated September 2024 Net Sales at Rs 29.15 crore, up 52% Y-o-Y
05.06.2025
3B BlackBio Dx Standalone March 2025 Net Sales at Rs 23.02 crore, up 4.7% Y-o-Y
03.06.2025
3B BlackBio Dx Consolidated March 2025 Net Sales at Rs 22.50 crore, down 2.19% Y-o-Y
05.03.2025
3B BlackBio Dx Consolidated December 2024 Net Sales at Rs 25.39 crore, up 43.71% Y-o-Y
28.11.2024
3B BlackBio Dx Consolidated September 2024 Net Sales at Rs 29.15 crore, up 52% Y-o-Y